These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 32547013)

  • 21. Biosurfactant coated silver and iron oxide nanoparticles with enhanced anti-biofilm and anti-adhesive properties.
    Khalid HF; Tehseen B; Sarwar Y; Hussain SZ; Khan WS; Raza ZA; Bajwa SZ; Kanaras AG; Hussain I; Rehman A
    J Hazard Mater; 2019 Feb; 364():441-448. PubMed ID: 30384254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasmall AgNP-Impregnated Biocompatible Hydrogel with Highly Effective Biofilm Elimination Properties.
    Haidari H; Kopecki Z; Bright R; Cowin AJ; Garg S; Goswami N; Vasilev K
    ACS Appl Mater Interfaces; 2020 Sep; 12(37):41011-41025. PubMed ID: 32840353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-biofilm efficacy of silver nanoparticles against MRSA and MRSE isolated from wounds in a tertiary care hospital.
    Ansari MA; Khan HM; Khan AA; Cameotra SS; Alzohairy MA
    Indian J Med Microbiol; 2015; 33(1):101-9. PubMed ID: 25560011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The differential activity of aminoglycoside antibiotics with rifampin explored in a kinetic in vitro model of implant-associated infection (Staphylococcus epidermidis).
    Richards GK; Morcos RJ; Gagnon RF
    Adv Perit Dial; 1994; 10():183-8. PubMed ID: 7999823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibacterial and antibiofilm potential of silver nanoparticles against antibiotic-sensitive and multidrug-resistant Pseudomonas aeruginosa strains.
    de Lacerda Coriolano D; de Souza JB; Bueno EV; Medeiros SMFRDS; Cavalcanti IDL; Cavalcanti IMF
    Braz J Microbiol; 2021 Mar; 52(1):267-278. PubMed ID: 33231865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro testing of antimicrobial activity of bone cement.
    Alt V; Bechert T; Steinrücke P; Wagener M; Seidel P; Dingeldein E; Domann E; Schnettler R
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4084-8. PubMed ID: 15504825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic antibacterial effects of curcumin modified silver nanoparticles through ROS-mediated pathways.
    Song Z; Wu Y; Wang H; Han H
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():255-263. PubMed ID: 30889699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of synergistic antibacterial effect of silver nanoparticles and ebselen.
    Chen X; Chen H; Zhang H; Peng Y; Deng F; Gao J; Chai C; Tang S; Zuo X; Lu J; Du H
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3338-3349. PubMed ID: 31387398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro anti-biofilm activity of a biphasic gentamicin-loaded calcium sulfate/hydroxyapatite bone graft substitute.
    Butini ME; Cabric S; Trampuz A; Di Luca M
    Colloids Surf B Biointerfaces; 2018 Jan; 161():252-260. PubMed ID: 29096369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanosilver-Decorated Biodegradable Mesoporous Organosilica Nanoparticles for GSH-Responsive Gentamicin Release and Synergistic Treatment of Antibiotic-Resistant Bacteria.
    Li H; Li D; Chen F; Yang C; Li X; Zhang Y; Hua C; Ma X; Zhao X; Shao D; Wang Y; Ming L
    Int J Nanomedicine; 2021; 16():4631-4642. PubMed ID: 34262273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.
    Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D
    Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic Antibacterial Efficacy of Biogenic Synthesized Silver Nanoparticles using Ajuga bractosa with Standard Antibiotics: A Study Against Bacterial Pathogens.
    Nazer S; Andleeb S; Ali S; Gulzar N; Iqbal T; Khan MAR; Raza A
    Curr Pharm Biotechnol; 2020; 21(3):206-218. PubMed ID: 31573882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation Optimization of Chitosan-Stabilized Silver Nanoparticles Using In Vitro Antimicrobial Assay.
    Pansara C; Chan WY; Parikh A; Trott DJ; Mehta T; Mishra R; Garg S
    J Pharm Sci; 2019 Feb; 108(2):1007-1016. PubMed ID: 30244012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibacterial-nanocomposite bone filler based on silver nanoparticles and polysaccharides.
    Porrelli D; Travan A; Turco G; Crosera M; Borgogna M; Donati I; Paoletti S; Adami G; Marsich E
    J Tissue Eng Regen Med; 2018 Feb; 12(2):e747-e759. PubMed ID: 27860429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-infection silver nanoparticle immobilized biomaterials facilitated by argon plasma grafting technology.
    Ambi A; Parikh N; Vera C; Burns K; Montano N; Sciorra L; Epstein J; Zeng D; Traba C
    Biofouling; 2018 Mar; 34(3):273-286. PubMed ID: 29447471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms.
    Gomes F; Teixeira P; Ceri H; Oliveira R
    Indian J Med Res; 2012 Apr; 135(4):542-7. PubMed ID: 22664505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanical, material, and antimicrobial properties of acrylic bone cement impregnated with silver nanoparticles.
    Slane J; Vivanco J; Rose W; Ploeg HL; Squire M
    Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():188-96. PubMed ID: 25579913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus.
    Tan H; Peng Z; Li Q; Xu X; Guo S; Tang T
    Biomaterials; 2012 Jan; 33(2):365-77. PubMed ID: 22014946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oligodynamic Boons of Daptomycin and Noble Metal Nanoparticles Packaged in an Anti-MRSA Topical Gel Formulation.
    Chakravarty I; Kundu S
    Curr Pharm Biotechnol; 2019; 20(9):707-718. PubMed ID: 31223082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergy between antibiotics and natural agents results in increased antimicrobial activity against Staphylococcus epidermidis.
    Abidi SH; Ahmed K; Sherwani SK; Kazmi SU
    J Infect Dev Ctries; 2015 Sep; 9(9):925-9. PubMed ID: 26409732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.